new glp-1 retatrutide Gwyneth Paltrow, Andrew Huberman & GLP-1 vs Retatrutide for Fat

Learn the records and tests that prove exposure, diagnosis, and causation to build a stronger case.

Unlike Rybelsus, which was the first oral GLP-1 medication but still a peptide, orforglipron is the first non-peptide oral GLP-1 receptor agonist

The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease

With the emergence of GLP-1s, there is a divide between patient perception of the medication and how clinical science views it

We have made more scientific improvements in its design, not only with a larger capacity, but also very lightweight

This review examines the biological mechanisms underlying GLP-1 RA therapy in MASLD/MASH, analyzes the mechanistic distinctions between mono-, dual-, and triple agonists, and synthesizes current clinical evidence supporting their utilization in individuals with this condition.